A probability prediction rule for malignant cervical lymphadenopathy using sonography

Head and Neck

Volumn 22, Issue 3, 2000, Pages 223-228

  Wu, Chih Hsiu ^a   Lee, May Meei Shyuan ^b   Huang, Kuo Chin ^a   Ko, Jenq Yuh ^a   Sheen, Tzung Shiahn ^a   Hsieh, Fon Jou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cervical lymphadenopathy; Malignancy; Prediction rule; Sonography

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; ECHOGRAPHY; FEMALE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SARCOMA; SENSITIVITY AND SPECIFICITY; SEX FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0034002289     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(200005)22:3<223::AID-HED3>3.0.CO;2-D     Document Type: Article

References (29)

1. Rubaltelli L, Proto E, Salmaso R, et al. Sonography of abnormal lymph nodes in vitro: correlation of sonographic and histologic findings. AJR Am J Roentgenol 1990;155: 1241.
2. Vassallo P, Wernecke K, Roos N, et al. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992;183:215.
3. Vassallo P, Edel G, Roos N, et al. In-vitro high-resolution ultrasonography of benign and malignant lymph nodes: a sonographic-pathologic correlation. Invest Radiol 1993; 28:698.
4. Ahuja A, Ying M, King W, et al. A practical approach to ultrasound of cervical lymph nodes. J Laryngol Otol 1997; 111:245.
5. Eichhorn T, Schroeder HG. Ultrasound in metastatic neck disease. ORL J Otorhinolaryngol Relat Spec 1993;55:258.
6. Toriyabe Y, Nishimura T, Kita S, et al. Differentiation between benign and metastatic cervical lymph nodes with ultrasound. Clin Radiol 1997;52:927.
7. Chang DB, Yuan A, Yu CJ, et al. Differentiation of benign and malignant cervical lymph nodes with color Doppler sonography. AJR Am J Roentgenol 1994;162:965.
8. Steinkamp HJ, Maurer J, Cornehl M, et al. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol 1994;251:404.
9. Choi MY, Lee JW, Jang KJ. Distinction between benign and malignant causes of cervical, axillary, and inguinal lymphadenopathy: value of Doppler spectral waveform analysis. AJR Am J Roentgenol 1995;165:981.
10. Tschammler A, Wirkner H, Ott G, et al. Vascular patterns in reactive and malignant lymphadenopathy. Eur Radiol 1996;6:473.
11. Na DG, Lim HK, Byun HS, et al. Differential diagnosis of cervical lymphadenopathy: usefulness of color Doppler sonography. AJR Am J Roentgenol 1997;168:1311.
12. Wu CH, Shih JC, Chang YL, et al. Two-dimensional and three-dimensional power Doppler classification of vascular patterns in cervical lymphadenopathies. J Ultrasound Med 1998;17:459.
13. Wu CH, Chang YL, Hsu WC, et al. Usefulness of Doppler spectral analysis and power Doppler sonography in the differentiation of cervical lymphadenopathies. AJR Am J Roentgenol 1998;171:503.
14. Wasson JH, Sox HC, Neff RK, et al. Clinical prediction rules: applications and methodological standards. N Engl J Med 1985;313:793.
15. Bude RO, Rubin JM. Power Doppler sonography. Radiology 1996;200:21.
16. Tohnosu N, Onada S, Isono K. Ultrasonographic evaluation of cervical lymph node metastasis in esophageal cancer with special reference between the short to long axis ratio (S/L) and the cancer content. J Clin Ultrasound 1989;17:101.
17. Evans RM, Ahuja A, Metreweli C. The linear echogenic hilus in cervical lymphadenopathy-a sign of benignity or malignancy? Clin Radiol 1993;47:262.
18. Hosmer DW, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DW, Lemeshow S, editors. Applied logistic regression. New York: John Wiley & Sons; 1989. p 82.
19. Sato N, Kawabe R, Fujita K, et al. Differential diagnosis of cervical lymphadenopathy with intranodal color Doppler flow signals in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:482.
20. Yoshida H, Yusa H, Ueno E, et al. Ultrasonographic evaluation of small cervical lymph nodes in head and neck cancer. Ultrasound Med Biol 1998;24:621.
21. Toriyabe Y, Nishimura T, Kita S, et al. Differentiation between benign and metastatic cervical lymph nodes with ultrasound. Clin Radiol 1997;52:927.
22. Bruneton JN, Balu-Maestro C, Marcy PY, et al. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994;13:87.
23. Ying M, Ahuja A, Brook F, et al. Sonographic appearance and distribution of normal cervical lymph nodes in a Chinese population. J Ultrasound Med 1996;15:431.
24. Eichhorn Th, Schroeder HG, Glanz H, et al. Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases [abstract]. Laryngologie Rhinologie Otologie 1987;66:266.
25. Bruneton JN, Roux P, Caramella E, et al. Ear, nose, throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology 1984;152:771.
26. Takes RP, Knegt P, Manni JJ et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996;198:819.
27. van den Brekel MWM, Castelijns JA, Stel HV, et al. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11.
28. Donahue BJ, Cruickshank JC, Bishop JW. The diagnostic value of fine needle aspiration biopsy of head and neck masses. ENT J 1995;74:483.
29. Atula TS, Grenman R, Varpula MJ. Palpation, ultrasound, and ultrasound-guided fine-needle aspiration cytology in the assessment of cervical lymph node status in head and neck cancer patients. Head Neck 1996;18:545.